Abstract:To the Editor: The cardiac sodium channel gene (SCN5A) plays a key role in cardiac electrophysiology. Mutations in the gene have been implicated in a broad spectrum of familial cardiac arrhythmias, including long QT syndrome (LQTS), idiopathic ventricular fibrillation, cardiac conduction disease, and congenital sick sinus syndrome. In 2002, Splawski et al.,1 taking a new step in the genetic studies of arrhythmia, reported that a common polymorphism Y1102 in SCN5A might increase the risk of heart arrhythmia in members of the population at large. In addition, previous studies have suggested that some mild LQTS mutations might cause drug-induced LQTS, leading to the expectation that polymorphisms of LQTS-related genes (including SCN5A) will potentially provide useful information on acquired cardiac arrhythmia.2,3 The polymorphisms of SCN5A gene have been well studied in American and Japanese but not in Chinese. In this letter, we systematically analyzed a large data set of samples to determine the polymorphisms of SCN5A gene in Chinese Han nationality, and hence their contribution to cardiac arrhythmias. DNA samples of 240 independent healthy volunteers from Han nationality in China were directly sequenced. A total of five SNPs were identified, including three novel SNPs: one synonymous SNP in exon2 (G87A, Ala29Ala), one regulatory SNP in 3′ untranslated region (G6174A), and one in intron 23 adjacent to donor splicing site (4245 + 82A>G). A1673G (His558Arg) and C5457T (Asp1819Asp) had been reported in American and Japanese.4–6 S1102Y and the other 10 reported SNPs could not be detected in Chinese Hans. The frequencies of the five SNPs were as follows: G87A 27.8%, A1673G 10.6%, 4245 + 82A>G 32.7%, C5457T 41.6%, and G6174A 44.9%. Genotype distributions of all loci were in Hardy-Weinberg equilibrium in healthy volunteers (all P > 0.05). Comparing the distribution of A1673G and C5457T in Chinese Han population with those in other ethnic populations, we observed that there was no significantly statistical difference in the frequency of A1673G among different ethical populations (all P > 0.05). The frequency of C5457T in Chinese Han population was similar to that observed in Japanese (P > 0.5), but significantly higher than that in American (P < 0.005). To determine the correlation of identified SNPs with cardiac arrhythmias, 78 unrelated patients who suffered from cardiac arrhythmias including syncope, aborted sudden death, documented ventricular tachyarrhythmia, and acquired long QT syndrome were recruited. Of these identified SNPs, only the distribution of A1673G in arrhythmia patients significantly differed from that in healthy volunteers, and the allele G1673 was overrepresented inpatients with a value of P = 0.0000033. The likelihood of displaying signs of arrhythmia in a G1673 carrier (G, A and G, G) yielded an odds ratio of 3.01 [95% confidence interval 1.59 to 5.69, P < 0.005]. The odds ratio was not significantly altered after controlling for age and gender (P < 0.005). A1673G is a nonsynonymous SNP in the Na+channel interdomain cytoplasmic linker, resulting in an amino acid change from histidine to arginine. Recently, a series studies about a common SCN5A polymorphism A1673G (H558R) suggested that it could modulate the biophysical effects of a nearby mutation within the same gene.7,8 However, the incidence of it has not been systematically evaluated in a large set of patients with cardiac arrhythmia. Our results suggest it might be involved in susceptibility to cardiac arrhythmias in Chinese Han population. Additional studies will be required not only to detect its more exact prevalence rate with a larger sample size in cardiac arrhythmia but also to investigate the possible biophysical effects of A1673G on the channel function in coordination with other polymorphisms.

SCN1A and SCN2A Polymorphisms Are Associated with Response to Valproic Acid in Chinese Epilepsy Patients

Effect of SCN1A and SCN2A gene polymorphisms on the efficacy of valproic acid treatment in Chinese children with epilepsy

Effects of SCN1A and SCN2A Polymorphisms on Responsiveness to Valproic Acid Monotherapy in Epileptic Children

Polymorphisms of ABAT, SCN2A and ALDH5A1 May Affect Valproic Acid Responses in the Treatment of Epilepsy in Chinese.

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

Correlation of MCT1 and ABCC2 Gene Polymorphisms with Valproic Acid Resistance in Patients with Epilepsy on Valproic Acid Monotherapy

Single-nucleotide polymorphisms in SCN5A gene in Chinese Han population and their correlation with cardiac arrhythmias

Association of single nucleotide polymorphisms of SLCO1 A2 , SLCO2 B1 and SLCO1 B1 genes with the effectiveness of valproic acid in epileptic patients

ABCC2 rs2273697 is associated with valproic acid concentrations in patients with epilepsy on valproic acid monotherapy.

Influence of transporter genetic polymorphisms on valproic acid blood concentration and clinical efficacy of epilepsy patients

The Influence of Cytochrome Oxidase CYP2A6, CYP2B6, and CYP2C9 Polymorphisms on the Plasma Concentrations of Valproic Acid in Epileptic Patients

Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients.

Abcb1, Abcc2, Scn1a, Scn2a, Gabra1 Gene Polymorphisms And Drug Resistant Epilepsy In The Chinese Han Population

Effects of UGT1A6, UGT2B7, and CYP2C9 Genotypes on Plasma Concentrations of Valproic Acid in Chinese Children with Epilepsy

Association of SCN1A Polymorphisms rs3812718 and rs2298771 with Epilepsy

Specific OCT1 and ABCG2 Polymorphisms Are Associated with Lamotrigine Concentrations in Chinese Patients with Epilepsy

Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy

Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients

Case–control Association Study of Polymorphisms in the Voltage-Gated Sodium Channel Genes SCN1A , SCN2A , SCN3A , SCN1B , and SCN2B and Epilepsy

Genotypic and phenotypic characteristics of sodium channel-associated epilepsy in Chinese population

The association of adjusted plasma valproic acid concentration with CYP2C9 gene polymorphism in patients with epilepsy: a systematic review and meta-analysis